As of 2025-07-15, the Gross Margin of Redhill Biopharma Ltd (RDHL) is 60.3%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 60.3% |
2023-12-31 | 47% |
2022-12-31 | 46.1% |
2021-12-31 | 52.8% |
2020-12-31 | 43.9% |
2019-12-31 | 64.1% |
2018-12-31 | 66% |
2017-12-31 | 46.9% |
2016-12-31 | 100% |
2015-12-31 | - |